国科大重庆医院与重庆学院联合申报获批“肝胆胰疾病智慧诊疗工程重庆市重点实验室”

2021-06-08 重庆市人民医院 重庆市人民医院

图片

 

“肝胆皆冰雪,表里俱澄澈。”中国科学院大学重庆医院肝胆胰腺外科研究所王槐志主任团队长期坚持以科学思维解决临床问题,构造“临床—基础—临床”闭环,不断推进疾病诊疗水平提升。

为了解决“我国肝癌、胆管癌和胰腺癌的发生率和死亡率始终高居不下,严重威胁人民健康”这一迫切问题,研究所牵头进行“医工结合、院校融合”实践,发起并推进“肝胆胰疾病智慧诊疗工程重庆市重点实验室”建设工作。融合中国科学院大学重庆医院和中国科学院重庆研究院的多学科力量,构建了深度融合医学、生物学、信息学、材料学、设备工程学和计算机科学等前沿学科的重点实验室,筑造了涵盖智能诊疗装备、智能诊疗环境、智能精准诊疗和诊疗认知决策的实验室学科发展体系,不断为肝胆胰疾病诊疗过程的智能化和精准化提供了科学理论基础和关键技术支撑,为肝胆胰疾病精准诊疗的实现和民生需求的保障,夯实了基础。

图片

医院领导及专家审议

实验室后续发展规划方案

图片

王槐志主任代表实验室团队

向评审专家汇报实验室建

设运行情况

图片

实验室现场考察

图片

实验室现场考察

此次重庆市重点实验室的获批,我院肝胆胰腺外科研究所的发展迎来了又一里程碑,起源于中国第一个肝胆胰疾病专科病房(由著名肝胆外科专家冉瑞图教授1961年创建的重庆市外科医院肝胆外科)的中国科学院大学重庆医院肝胆胰腺外科研究所,已成为集重庆市临床重点专科、重庆市首席专家工作室、重庆市重点实验室于一体的唯一肝胆胰腺外科中心。

此次重庆市重点实验室的获批,更是对近几年来中国科学院大学“院校融合”实践的肯定,对多学科优势融合走出健康中国新路径的期望。实验室团队必定全力以赴,为肝胆胰疾病诊治的数字化、智能化、精准化提供更多的方案,为百姓提供更好的健康服务。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1991017, encodeId=c7c3199101e0a, content=<a href='/topic/show?id=a1f7835282a' target=_blank style='color:#2F92EE;'>#胆胰疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83528, encryptionId=a1f7835282a, topicName=胆胰疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 07 04:46:16 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069674, encodeId=c0d020696e4cb, content=<a href='/topic/show?id=4f9f4102804' target=_blank style='color:#2F92EE;'>#国科大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41028, encryptionId=4f9f4102804, topicName=国科大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Fri Dec 31 20:46:16 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688584, encodeId=b9e216885843a, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Mon Jan 10 15:46:16 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971902, encodeId=9ad79e190212, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/f68c5332fff04294b99141d8b88d3ec2/a494511dd06348b7a3b1343acc4c272c.jpg, createdBy=77075513887, createdName=ms5000001437056934, createdTime=Tue Jun 08 17:10:00 CST 2021, time=2021-06-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1991017, encodeId=c7c3199101e0a, content=<a href='/topic/show?id=a1f7835282a' target=_blank style='color:#2F92EE;'>#胆胰疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83528, encryptionId=a1f7835282a, topicName=胆胰疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 07 04:46:16 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069674, encodeId=c0d020696e4cb, content=<a href='/topic/show?id=4f9f4102804' target=_blank style='color:#2F92EE;'>#国科大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41028, encryptionId=4f9f4102804, topicName=国科大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Fri Dec 31 20:46:16 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688584, encodeId=b9e216885843a, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Mon Jan 10 15:46:16 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971902, encodeId=9ad79e190212, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/f68c5332fff04294b99141d8b88d3ec2/a494511dd06348b7a3b1343acc4c272c.jpg, createdBy=77075513887, createdName=ms5000001437056934, createdTime=Tue Jun 08 17:10:00 CST 2021, time=2021-06-08, status=1, ipAttribution=)]
    2021-12-31 jml2009
  3. [GetPortalCommentsPageByObjectIdResponse(id=1991017, encodeId=c7c3199101e0a, content=<a href='/topic/show?id=a1f7835282a' target=_blank style='color:#2F92EE;'>#胆胰疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83528, encryptionId=a1f7835282a, topicName=胆胰疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 07 04:46:16 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069674, encodeId=c0d020696e4cb, content=<a href='/topic/show?id=4f9f4102804' target=_blank style='color:#2F92EE;'>#国科大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41028, encryptionId=4f9f4102804, topicName=国科大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Fri Dec 31 20:46:16 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688584, encodeId=b9e216885843a, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Mon Jan 10 15:46:16 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971902, encodeId=9ad79e190212, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/f68c5332fff04294b99141d8b88d3ec2/a494511dd06348b7a3b1343acc4c272c.jpg, createdBy=77075513887, createdName=ms5000001437056934, createdTime=Tue Jun 08 17:10:00 CST 2021, time=2021-06-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1991017, encodeId=c7c3199101e0a, content=<a href='/topic/show?id=a1f7835282a' target=_blank style='color:#2F92EE;'>#胆胰疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83528, encryptionId=a1f7835282a, topicName=胆胰疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Thu Apr 07 04:46:16 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069674, encodeId=c0d020696e4cb, content=<a href='/topic/show?id=4f9f4102804' target=_blank style='color:#2F92EE;'>#国科大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41028, encryptionId=4f9f4102804, topicName=国科大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Fri Dec 31 20:46:16 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688584, encodeId=b9e216885843a, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Mon Jan 10 15:46:16 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971902, encodeId=9ad79e190212, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/f68c5332fff04294b99141d8b88d3ec2/a494511dd06348b7a3b1343acc4c272c.jpg, createdBy=77075513887, createdName=ms5000001437056934, createdTime=Tue Jun 08 17:10:00 CST 2021, time=2021-06-08, status=1, ipAttribution=)]
    2021-06-08 ms5000001437056934

    谢谢

    0

相关资讯

科技部:组织申报企业国家重点实验室相关通知

8月19日,科技部发布关于组织申报企业国家重点实验室的通知(国科发基〔2014〕228号),通知指出科技部拟启动第三批企业国家重点实验室的建设工作,重点围绕节能环保、新一代信息技术、生物、高端装备制造、新能源、新材料、新能源汽车等战略性新兴产业和若干重要产业中16个方向,进一步完善企业国家重点实验室布局,引领和带动行业技术进步。其中生物医药领域的转化医学与创新药物、农业生物技术领域的生物育种位

全军肝病和艾滋病防治重点实验室成立

近日,全军肝病和艾滋病防治重点实验室在解放军第302医院成立,该实验室将加强科研攻关,着力解决我国肝病和艾滋病等重大疾病诊治的关键性难题,不断提高我国肝病和艾滋病的防治水平。 当前,乙型、丙型病毒性肝炎等感染性肝病,以及酒精、脂肪、自身免疫性肝病等非感染性肝病和艾滋病等重大疾病严重危害着人类健康,我国医学界尚且缺乏行之有效的治疗手段。 全军肝病和艾滋病防治重点实验室将紧紧依托全军唯一传染病医院

45家!国家药监局公布首批重点实验室

7月15日,国家药监局官网发布了关于认定首批重点实验室的通知,共计45家实验室位列榜单。

中国医学科学院成体干细胞转化研究重点实验室揭牌

中国医学科学院成体干细胞转化研究重点实验室。7月29日,成立揭牌仪式在贵州医科大学举行。